Medicine:Cevira
From HandWiki
This article may have been created or edited in return for undisclosed payments, a violation of Wikipedia's terms of use. (June 2019) |
Cevira is in development as a local treatment for Cervical intraepithelial neoplasia lesions and human papilloma virus (HPV) of the cervix without damaging healthy tissue. With Cevira, Photocure aims to develop the first non-surgical treatment for precancerous cervical lesions using photodynamic therapy (PDT). Cevira treatment is administered locally and remains in contact with the cervix to deliver treatment for up to 24 hours. A cup holds the ointment against the cervix for initial absorption. After a few hours, a light source within the cup emits light at a specific wavelength so the Active Pharmaceutical Ingredient, hexylaminolevulinate (HAL), reacts with the tissue.[1][2]
References
- ↑ "Photodynamic Device Developed to Treat Precancerous Cervical Lesions". Medical Advice Network. 18 March 2011. http://www.medicaldevice-network.com/news/news113548.html/. Retrieved 2013-06-06.
- ↑ Fontanazza, Maria (April 18, 2011). "Drug and Light Join Forces to Fight Precancerous Lesions". MDDI. http://www.mddionline.com/article/drug-and-light-join-forces-fight-precancerous-lesions. Retrieved 2013-06-06.
Original source: https://en.wikipedia.org/wiki/Cevira.
Read more |